These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22704999)

  • 1. 3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: molecular modeling and pharmacological studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Squarcialupi L; Costagli C; Galli A; Ghelardini C; Pugliese AM; Maraula G; Coppi E; Pellegrini-Giampietro DE; Pedata F; Sabbadin D; Moro S
    Eur J Med Chem; 2012 Aug; 54():470-82. PubMed ID: 22704999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies.
    Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A; Ghelardini C; Galeotti N; Gratteri P; Sgrignani J; Deflorian F; Moro S
    J Med Chem; 2006 Oct; 49(20):6015-26. PubMed ID: 17004715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.
    Calabri FR; Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A
    Eur J Med Chem; 2005 Sep; 40(9):897-907. PubMed ID: 15919134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity.
    Koller M; Lingenhoehl K; Schmutz M; Vranesic IT; Kallen J; Auberson YP; Carcache DA; Mattes H; Ofner S; Orain D; Urwyler S
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3358-61. PubMed ID: 21531559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.
    Inami H; Shishikura JI; Yasunaga T; Hirano M; Kimura T; Yamashita H; Ohno K; Sakamoto S
    Chem Pharm Bull (Tokyo); 2019; 67(7):699-706. PubMed ID: 31257325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists.
    Catarzi D; Lenzi O; Colotta V; Varano F; Poli D; Filacchioni G; Lingenhöhl K; Ofner S
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):908-11. PubMed ID: 20606335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.
    Inami H; Shishikura J; Yasunaga T; Ohno K; Yamashita H; Kato K; Sakamoto S
    Bioorg Med Chem; 2015 Apr; 23(8):1788-99. PubMed ID: 25792143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors.
    Wilding TJ; Huettner JE
    Mol Pharmacol; 1996 Mar; 49(3):540-6. PubMed ID: 8643094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Substituted phenylalanines as selective AMPA- and kainate receptor ligands.
    Szymańska E; Pickering DS; Nielsen B; Johansen TN
    Bioorg Med Chem; 2009 Sep; 17(17):6390-401. PubMed ID: 19656686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists.
    Colotta V; Catarzi D; Varano F; Calabri FR; Filacchioni G; Costagli C; Galli A
    Bioorg Med Chem Lett; 2004 May; 14(9):2345-9. PubMed ID: 15081038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists.
    Orain D; Ofner S; Koller M; Carcache DA; Froestl W; Allgeier H; Rasetti V; Nozulak J; Mattes H; Soldermann N; Floersheim P; Desrayaud S; Kallen J; Lingenhoehl K; Urwyler S
    Bioorg Med Chem Lett; 2012 Jan; 22(2):996-9. PubMed ID: 22197388
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Møllerud S; Hansen RB; Pallesen J; Temperini P; Pasini D; Bornholt J; Nielsen B; Mamedova E; Chalupnik P; Paternain AV; Lerma J; Diaz-delCastillo M; Andreasen JT; Frydenvang K; Kastrup JS; Johansen TN; Pickering DS
    ACS Chem Neurosci; 2019 Nov; 10(11):4685-4695. PubMed ID: 31622082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
    Radenovic L; Selakovic V
    Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synaptic activation of kainate receptors.
    Vignes M; Collingridge GL
    Nature; 1997 Jul; 388(6638):179-82. PubMed ID: 9217158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonists: synthesis and structure-activity relationships of 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and related compounds.
    Ohmori J; Kubota H; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1996 Mar; 39(6):1331-8. PubMed ID: 8632440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.